JAK3 and cancer: As expected, the mRNA levels of JAK3 were significantly increased in STAD during subgroup analyses based on the race, gender, age, H. pylori infection status, histological subtype, tumor grade, cancer stage, and nodal metastasis status of patients (Figure 2).